531 related articles for article (PubMed ID: 10404910)
1. The role of APOE epsilon4 in modulating effects of other risk factors for cognitive decline in elderly persons.
Haan MN; Shemanski L; Jagust WJ; Manolio TA; Kuller L
JAMA; 1999 Jul; 282(1):40-6. PubMed ID: 10404910
[TBL] [Abstract][Full Text] [Related]
2. Estrogen use, APOE, and cognitive decline: evidence of gene-environment interaction.
Yaffe K; Haan M; Byers A; Tangen C; Kuller L
Neurology; 2000 May; 54(10):1949-54. PubMed ID: 10822435
[TBL] [Abstract][Full Text] [Related]
3. Cerebrovascular disease, APOE epsilon4 allele and cognitive decline in a cognitively normal population.
Qiu C; Winblad B; Fratiglioni L
Neurol Res; 2006 Sep; 28(6):650-6. PubMed ID: 16945218
[TBL] [Abstract][Full Text] [Related]
4. Risk factors for mild cognitive impairment in the Cardiovascular Health Study Cognition Study: part 2.
Lopez OL; Jagust WJ; Dulberg C; Becker JT; DeKosky ST; Fitzpatrick A; Breitner J; Lyketsos C; Jones B; Kawas C; Carlson M; Kuller LH
Arch Neurol; 2003 Oct; 60(10):1394-9. PubMed ID: 14568809
[TBL] [Abstract][Full Text] [Related]
5. Fourteen-year longitudinal study of vascular risk factors, APOE genotype, and cognition: the ARIC MRI Study.
Knopman DS; Mosley TH; Catellier DJ; Coker LH;
Alzheimers Dement; 2009 May; 5(3):207-14. PubMed ID: 19362884
[TBL] [Abstract][Full Text] [Related]
6. APOE and cognitive decline in preclinical Alzheimer disease and non-demented aging.
Bunce D; Fratiglioni L; Small BJ; Winblad B; Bäckman L
Neurology; 2004 Sep; 63(5):816-21. PubMed ID: 15365129
[TBL] [Abstract][Full Text] [Related]
7. Memory complaints and APOE-epsilon4 accelerate cognitive decline in cognitively normal elderly.
Dik MG; Jonker C; Comijs HC; Bouter LM; Twisk JW; van Kamp GJ; Deeg DJ
Neurology; 2001 Dec; 57(12):2217-22. PubMed ID: 11756600
[TBL] [Abstract][Full Text] [Related]
8. APOE genotype and cognitive decline in a middle-aged cohort.
Blair CK; Folsom AR; Knopman DS; Bray MS; Mosley TH; Boerwinkle E;
Neurology; 2005 Jan; 64(2):268-76. PubMed ID: 15668424
[TBL] [Abstract][Full Text] [Related]
9. Longitudinal analysis of the effect of apolipoprotein E epsilon4 and education on cognitive performance in elderly subjects: the PAQUID study.
Winnock M; Letenneur L; Jacqmin-Gadda H; Dallongeville J; Amouyel P; Dartigues JF
J Neurol Neurosurg Psychiatry; 2002 Jun; 72(6):794-7. PubMed ID: 12023428
[TBL] [Abstract][Full Text] [Related]
10. Apolipoprotein E epsilon4 and change in cognitive functioning in community-dwelling older adults.
Swan GE; Lessov-Schlaggar CN; Carmelli D; Schellenberg GD; La Rue A
J Geriatr Psychiatry Neurol; 2005 Dec; 18(4):196-201. PubMed ID: 16306239
[TBL] [Abstract][Full Text] [Related]
11. The role of APOE-epsilon4 in longitudinal cognitive decline: MacArthur Studies of Successful Aging.
Bretsky P; Guralnik JM; Launer L; Albert M; Seeman TE;
Neurology; 2003 Apr; 60(7):1077-81. PubMed ID: 12682309
[TBL] [Abstract][Full Text] [Related]
12. A gender difference in the association between APOE genotype and age-related cognitive decline.
Mortensen EL; Høgh P
Neurology; 2001 Jul; 57(1):89-95. PubMed ID: 11445633
[TBL] [Abstract][Full Text] [Related]
13. Impact of APOE status on cognitive maintenance in healthy elderly persons.
Zehnder AE; Bläsi S; Berres M; Monsch AU; Stähelin HB; Spiegel R
Int J Geriatr Psychiatry; 2009 Feb; 24(2):132-41. PubMed ID: 18615849
[TBL] [Abstract][Full Text] [Related]
14. Stroke and apolipoprotein E epsilon4 are independent risk factors for cognitive decline: A population-based study.
Dik MG; Deeg DJ; Bouter LM; Corder EH; Kok A; Jonker C
Stroke; 2000 Oct; 31(10):2431-6. PubMed ID: 11022076
[TBL] [Abstract][Full Text] [Related]
15. Association between serum beta-carotene levels and decline of cognitive function in high-functioning older persons with or without apolipoprotein E 4 alleles: MacArthur studies of successful aging.
Hu P; Bretsky P; Crimmins EM; Guralnik JM; Reuben DB; Seeman TE
J Gerontol A Biol Sci Med Sci; 2006 Jun; 61(6):616-20. PubMed ID: 16799145
[TBL] [Abstract][Full Text] [Related]
16. Predictive utility of apolipoprotein E genotype for Alzheimer disease in outpatients with mild cognitive impairment.
Devanand DP; Pelton GH; Zamora D; Liu X; Tabert MH; Goodkind M; Scarmeas N; Braun I; Stern Y; Mayeux R
Arch Neurol; 2005 Jun; 62(6):975-80. PubMed ID: 15956169
[TBL] [Abstract][Full Text] [Related]
17. Association between apolipoprotein E epsilon4 and the rate of cognitive decline in community-dwelling elderly individuals with and without dementia.
Jonker C; Schmand B; Lindeboom J; Havekes LM; Launer LJ
Arch Neurol; 1998 Aug; 55(8):1065-9. PubMed ID: 9708956
[TBL] [Abstract][Full Text] [Related]
18. Apolipoprotein epsilon4 allele status, depressive symptoms, and cognitive decline in middle-aged and elderly persons without dementia.
Lavretsky H; Ercoli L; Siddarth P; Bookheimer S; Miller K; Small G
Am J Geriatr Psychiatry; 2003; 11(6):667-73. PubMed ID: 14609807
[TBL] [Abstract][Full Text] [Related]
19. Association of the Haptoglobin Gene Polymorphism With Cognitive Function and Decline in Elderly African American Adults With Type 2 Diabetes: Findings From the Action to Control Cardiovascular Risk in Diabetes-Memory in Diabetes (ACCORD-MIND) Study.
Beeri MS; Lin HM; Sano M; Ravona-Springer R; Liu X; Bendlin BB; Gleason CE; Guerrero-Berroa E; Soleimani L; Launer LJ; Ehrenberg S; Lache O; Seligman YK; Levy AP
JAMA Netw Open; 2018 Nov; 1(7):e184458. PubMed ID: 30646354
[TBL] [Abstract][Full Text] [Related]
20. The effect of apolipoprotein E epsilon4 in the relationships of smoking and drinking to cognitive function.
Carmelli D; Swan GE; Reed T; Schellenberg GD; Christian JC
Neuroepidemiology; 1999; 18(3):125-33. PubMed ID: 10202267
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
